Search Results
Mar 31, 2026, 22:02 ET Abbisko Therapeutics' FGFR4 Inhibitor Irpagratinib Granted Orphan Drug Designation by EMA for Hepatocellular Carcinoma
Orphan Drug Designation is a key incentive established by the EMA to facilitate the development and authorisation of medicines for rare diseases. The ODD granted to irpagratinib not only reflects regulatory recognition of its potential clinical value and need, but also provides access
More news about: Abbisko
Mar 31, 2026, 20:13 ET Court Rules Li Rui Collection to Remain at the Hoover Institution, Stanford University
democratic China. As a senior member of the Chinese Communist Party (CCP), Li was a witness to history from inside China's government, an extremely rare vantage point from which few records currently exist that are available to all for study. His archive includes his diaries, which he kept for eight
More news about: Hoover Institution at Stanford University
Mar 31, 2026, 18:10 ET Lightspeed Appoints Dr. Nathan Lang-Raad as Vice President of Business Development, Expands Senior Leadership Team
district leaders and collaborate with strategic advisors to bridge the gap between classroom technology and pedagogical efficacy."Nathan brings a rare blend of deep academic credibility and strategic vision," said David Solomon, CEO of Lightspeed. "His focus on the 'Science of Learning' and his firsthand
More news about: Lightspeed
Mar 31, 2026, 17:01 ET Longitude Rx Appoints Stacy Walton as Inaugural Chief Commercial Officer to Accelerate Growth and Market Expansion
record across specialty pharmacy and commercial strategy. At OptumRx, she led national clinical programs across oncology, immunology, neurology, and rare disease, and served as Senior Director overseeing contract negotiations and limited distribution drug network access. Most recently, she served as Senior
More news about: Longitude Rx
Mar 31, 2026, 15:24 ET CollectiveMinds LLC Places Robert Hollingsworth, PhD as Chief Scientific Officer of Protillion Biosciences
connects so deeply with the culture and mission of what they are building.""What makes Bob so exceptional is his rare ability to see the direct line between the differentiated capabilities of a novel platform and superior clinical outcomes," said Curtis Layton,
More news about: CollectiveMinds LLC
Mar 31, 2026, 14:23 ET South Seas purchases Rauschenberg property on Captiva
owner following the 2008 passing of Robert Rauschenberg, the 20th-century American artist."Given its location, this sale offered us a rare and compelling opportunity to acquire prime beachfront directly adjacent to our established resort, creating a seamless opportunity for integration
More news about: South Seas
Mar 31, 2026, 13:48 ET Patriots QB Drake Maye, Wife Ann Michael and 800+ Granite Teammates Raise $4.155 Million for Boston Children's Hospital
research community. From bench to bedside, scientists work on preventing, treating, and curing diseases that impact both children and adults, no matter how rare or complex the condition. Founded as a 20-bed hospital for children, Boston Children's is now a 491-bed comprehensive center for pediatric and adolescent
More news about: Granite Telecommunications, LLC
Mar 31, 2026, 12:17 ET MikeWorldWide Continues Rapid Growth of Public Affairs Practice, Taps Former Regional Director of Federal HHS and Principal Deputy Commissioner for NJ Department of Health Jackie Cornell as Vice President, Government Relations & Public Affairs and Head of the Firm's Trenton, NJ Office
longstanding relationships across the Executive Branch, legislative leadership, advocacy organizations, and regulated industries."Jackie brings rare depth across government, campaigns, and advocacy," said Michael Kempner, Founder and CEO of MikeWorldWide. "She understands how policy is shaped, how
More news about: MikeWorldWide
Mar 31, 2026, 11:35 ET Mediaspace Health Launches to Deliver Innovative Media Strategies for Agencies, Pharma and Healthcare Brands
Health, the Mediaspace Health team brings decades of omnichannel experience and regulatory awareness, as well as specialized expertise across oncology, rare disease, specialty conditions, and chronic care. With senior healthcare experts on every account, Mediaspace Health seamlessly integrates with client
More news about: Mediaspace Solutions
Mar 31, 2026, 11:32 ET Cell Therapy Market Size to Surpass USD 17.15 Billion by 2032, Driven by Chronic Disease Treatment and CAR-T Therapy Growth, Says New MMR Analysis
CRISPR Innovations: Driving Chronic and Rare Disease Treatments GloballGlobal Cell Therapy Market is accelerating, fueled by breakthroughs in CAR-T therapy, allogeneic cell therapies, and regenerative medicine. Rising prevalence of chronic and rare diseases and integration of gene-editing
More news about: Maximize Market Research Pvt. Ltd.
Mar 31, 2026, 11:30 ET Extell Development Company Appoints Andrew Chung as President and Co-Chief Executive Officer
"Andrew is a highly respected leader with a rare combination of development expertise and institutional investment experience," said Gary Barnett, Founder, Chairman & CEO of Extell Development
More news about: Extell Development Company
Mar 31, 2026, 11:15 ET DeuteRx Celebrates Women's History Month with Over a Decade of Pioneering Leadership in Drug Discovery
LLCLooking AheadBuilding on its proven drug discovery track, the DeuteRx team is advancing programs in spasticity, neuropathic pain, and rare dermatologic conditions. The company remains committed to applying the DECS strategy to create best-in-class therapeutics with clear clinical differentiation
More news about: DeuteRx LLC
Mar 31, 2026, 11:11 ET New FDA Plausible Mechanism Framework Spurs Development of Personalized In Vivo Prime Editing Platform for Urea Cycle Disorders
Guidance opens doors for rare disease treatments, but academic teams will likely need industry partners to meet rigor required for FDA approvalPHILADELPHIA, March 31, 2026 /PRNewswire/ -- Researchers
More news about: Children's Hospital of Philadelphia
Mar 31, 2026, 11:00 ET Alltrna Announces Approval to Initiate First-in-Human Clinical Trial of AP003, the First tRNA Therapeutic to Enter Clinical Trials
PTCs."Establishing initial clinical safety data for a new modality is a critical step to advancing what we believe is the first tRNA approach in the clinic for rare disease patients," Joanne Protano, President and Chief Financial Officer, Alltrna. "This trial enables us to characterize the safety and pharmacokinetics
More news about: Alltrna
Mar 31, 2026, 10:50 ET Why Rare Earth Magnets are the World's Most Dangerous Bottleneck
companies in rare earth magnet recycling, having pioneered the use of recycled rare earth elements in consumer electronics as far back as 2019, when it introduced them in the Taptic Engine of the iPhone 11. Today, nearly all magnets across Apple's device lineup are made with 100% recycled rare earth elements,
More news about: OilPrice.com
Mar 31, 2026, 10:04 ET /C O R R E C T I O N -- AbbVie/
throat after submental or submandibular area treatment.Rare side effects may happen in 1 to 10 out of 10,000 CoolSculpting® and CoolSculpting® Elite treatments (between 0.01% to 0.1%). One such rare side effect is a visible enlargement in the treated area,
More news about: AbbVie
Mar 31, 2026, 10:01 ET Angel's Envy Debuts 2026 Cask Strength Dual Release Featuring Annual Bourbon and First-Ever Age-Stated Rye
least ten years. This extended finishing enhances the rye's natural spice with layers of sweetness, richness, and complexity, resulting in a bold and rare expression that reflects both patience and craft. "Since launching our first Cask Strength Rye in 2023, we've consistently heard from consumers
More news about: Angel's Envy
Mar 31, 2026, 10:00 ET APCOR Highlights Cork's Unique Technical and Environmental Credentials Through New Integrated Communications Efforts
categories and help determine the industry leaders. Agency principals have years of experience in retail and distribution as well as communications, a rare combination that gives Colangelo & Partners invaluable insights into consumer purchasing behavior as well as the route-to-market opportunities and
More news about: The Portuguese Cork Association (APCOR)
Mar 31, 2026, 09:49 ET Veteran Tech Executive Scott Van Vliet Joins Xoriant's Board
Scott Van Vliet, said, "What excites me about Xoriant is the rare combination of deep engineering DNA, a clear Applied Intelligence vision, and the agility to move faster than companies many times its size. The next
More news about: Xoriant
Mar 31, 2026, 09:00 ET RARE Shareholder Alert: Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
March 31, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE).
More news about: The Gross Law Firm
Mar 31, 2026, 09:00 ET NEW CAMPAIGN "BEAT CANCER OFF" WANTS MEN TO MASTURBATE 21 OR MORE TIMES A MONTH
science into behavior change," said Yael Cohen, Co-Founder of FCancer. "The data around ejaculation frequency and prostate cancer risk is compelling. It's rare that science and behavior align this clearly, so yes, we're encouraging men to take their health into their own hands. Instead of burying that in a
More news about: FCancer
Mar 31, 2026, 08:51 ET ACS Expert to Present Multi-Bus Avionics Time Synchronization Strategies at NI Connect 2026
using NI-XNET and ARINC-825, demonstrating how hardware-timed frames deliver deterministic performance in mission-critical applications."It's rare for an avionics test system to be dealing with a single protocol today," says Sekel. "Aircrafts are managing four or five busses simultaneously, each
More news about: ACS
Mar 31, 2026, 08:47 ET M2 Group Strengthens Civil Engineering Leadership with Appointment of 30-Year Industry Veteran Brenda Shackleford
helping developers and owners navigate complex projects across the country, from small-box retail to large-scale commercial centers. Brenda brings a rare combination of technical depth and strategic vision across engineering, land development, and project teaming that strengthens client relationships
More news about: M2 Group
Mar 31, 2026, 08:45 ET Metallium Announces Off-Take Agreement with Indium Corporation for Critical & Precious Metals Including Gallium and Germanium
The company's patented Flash Joule Heating (FJH) technology enables the extraction of high-value materials, including gallium, germanium, antimony, rare earth elements and gold from feedstocks such as refinery scrap, e-waste and monazite. Aligned with U.S. strategic supply chain objectives, Metallium
More news about: Metallium Limited
Mar 31, 2026, 08:37 ET MAKO CAPITAL GROUP LAUNCHES PRIVATE EQUITY FIRM FOCUSED ON FOUNDER-LED BUSINESSES ACROSS HEALTHCARE AND FINANCIAL SERVICES
and partnership mindset that lower-middle market businesses need to grow into durable, world-class enterprises."The founding team brings a rare combination of institutional investing experience and operational leadership. Morales was part of the founding team that built BAML Capital Partners
More news about: Mako Capital Group